OSE Immunotherapeutics SA Profile Avatar - Palmy Investing

OSE Immunotherapeutics SA

OSE Immunotherapeutics SA focuses on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. Its products include Tedopi that is in Phase III clinical stage for the treatment of no…

Biotechnology
FR, Nantes [HQ]
OSE.PA/Financials
Supply · Problems · Premarket · Compliance

Supply Analysis

Supply Analysis
End of OSE.PA's Analysis
CIK: - CUSIP: F6913C100 ISIN: FR0012127173 LEI: - UEI: -
Secondary Listings
OSE.PA has no secondary listings inside our databases.